Zeltiq Aesthetics Inc  

(Public, NASDAQ:ZLTQ)   Watch this stock  
Find more results for ZLTQ
44.40
-1.36 (-2.97%)
Dec 9 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 43.53 - 46.00
52 week 18.41 - 46.00
Open 46.00
Vol / Avg. 1.12M/908,498.00
Mkt cap 1.72B
P/E 60.03
Div/yield     -
EPS 0.74
Shares 39.98M
Beta 1.02
Inst. own 123%
Feb 27, 2017
Q4 2016 ZELTIQ Aesthetics Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 29, 2016
ZELTIQ Aesthetics Inc at Piper Jaffray Healthcare Conference
Nov 17, 2016
ZELTIQ Aesthetics Inc at Canaccord Genuity Med Tech Conference - Webcast
Nov 16, 2016
ZELTIQ Aesthetics Inc at Stifel Healthcare Conference - Webcast
Nov 9, 2016
Q3 2016 ZELTIQ Aesthetics Inc Earnings Call
Nov 9, 2016
Q3 2016 ZELTIQ Aesthetics Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 5.45% 16.37%
Operating margin 12.25% 1.45%
EBITD margin - 2.39%
Return on average assets 10.89% 29.57%
Return on average equity 17.64% 42.91%
Employees 535 -
CDP Score - -

Address

4698 Willow Rd Ste 100
PLEASANTON, CA 94588-2806
United States - Map
+1-925-4742500 (Phone)
+1-925-4742599 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ZELTIQ Aesthetics, Inc. is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians. It also offers consumables, which are CoolSculpting procedure packs that are needed to perform procedures using its CoolSculpting system. CoolSculpting is a non-invasive fat reduction procedure. CoolSculpting utilizes its controlled cooling technology to selectively reduce stubborn fat bulges. The CoolSculpting system includes CoolSculpting control unit and CoolSculpting applicators. Its consumable procedure pack includes consumable CoolGels, CoolLiners and Geltraps. In addition, each consumable procedure pack includes a disposable computer cartridge that it markets as the CoolCard.

Officers and directors

Mark J. Foley Chairman of the Board, President, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
Taylor C. Harris Chief Financial Officer, Senior Vice President
Age: 40
Bio & Compensation  - Reuters
Keith J. Sullivan Chief Commercial Officer and President, North America
Age: 58
Bio & Compensation  - Reuters
Todd E. Zavodnick President, International
Bio & Compensation  - Reuters
Sergio Garcia-Rodriguez Senior Vice President, General Counsel and Corporate Secretary
Age: 54
Bio & Compensation  - Reuters
Leonard C. DeBenedictis Chief Technology Officer
Age: 74
Bio & Compensation  - Reuters
Carl H. Lamm Vice President of Operations
Age: 54
Bio & Compensation  - Reuters
Brad Hauser Vice President - Research and Development
Age: 39
Bio & Compensation  - Reuters
David J. Endicott Director
Age: 51
Bio & Compensation  - Reuters
Mary M. Fisher Independent Director
Age: 54
Bio & Compensation  - Reuters